Therapeutic pathology
11 – 20 of 157
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Pre- and Postoperative Antioxidant Use, Aryl Hydrocarbon Receptor (AhR) Activation and Clinical Outcome in Different Treatment Groups of Breast Cancer Patients
- Contribution to journal › Article
-
Mark
Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases
- Contribution to journal › Article
-
Mark
Preliminary evaluation of an automated autoencoder-UNet pipeline for chemical image segmentation and compression with reference to serial ground truth pathology
(2024) Data Science for Photonics and Biophotonics 2024 In Proceedings of SPIE - The International Society for Optical Engineering 13011.
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Entropy-based spatial heterogeneity analysis in pathological images for diagnostic applications
(2024) Data Science for Photonics and Biophotonics 2024 In Proceedings of SPIE - The International Society for Optical Engineering 13011.
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Quality of life for patients with advanced gastrointestinal cancer randomised to early specialised home-based palliative care: the ALLAN trial
- Contribution to journal › Article
-
Mark
The Vitamin D Receptor as a Prognostic Marker in Breast Cancer-A Cohort Study
- Contribution to journal › Article
-
Mark
Stromal cartilage oligomeric matrix protein as a tumorigenic driver in ovarian cancer via Notch3 signaling and epithelial-to-mesenchymal transition
- Contribution to journal › Article
-
Mark
Pancreatic cancer evolution across space and time: From diagnosis to terminal disease
(2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
The prognostic value of programmed death-ligand 1 (PD-L1) expression in resected colorectal cancer without neoadjuvant therapy - differences between antibody clones and cell types
- Contribution to journal › Article
-
Mark
High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome
- Contribution to journal › Article
